Cite
MLA Citation
Bilal Tariq et al.. “A phase 1, open-label, randomized drug–drug interaction study of zanubrutinib with moderate or strong CYP3A inhibitors in patients with B-cell malignancies.” Leukemia & lymphoma, vol. 64, no. 2, 2023, pp. 329–338. http://access.bl.uk/ark:/81055/vdc_100179399972.0x000039